APROCITENTAN
Product
IDORSIA PHARMACEUTICALS US INC
Total Payments
$77,374
Transactions
76
Doctors
8
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $77,374 | 76 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $49,881 | 8 | 64.5% |
| Travel and Lodging | $25,865 | 26 | 33.4% |
| Food and Beverage | $1,628 | 42 | 2.1% |
Top Doctors Receiving Payments for APROCITENTAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | West Hollywood, CA | $16,524 | 12 |
| , MD | Specialist | New York, NY | $12,861 | 12 |
| , M.D | Internal Medicine | Ann Arbor, MI | $11,060 | 11 |
| , MD | Internal Medicine | Stanford, CA | $10,277 | 8 |
| , M.D | Internal Medicine | Reno, NV | $8,987 | 10 |
| , M.D | Internal Medicine | Chicago, IL | $8,983 | 8 |
| , MD | Nephrology | Philadelphia, PA | $6,221 | 7 |
| , M.D., S.M | Internal Medicine | New York, NY | $2,460 | 8 |
Ad
Manufacturing Companies
- IDORSIA PHARMACEUTICALS US INC $77,374
Product Information
- Type Product
- Total Payments $77,374
- Total Doctors 8
- Transactions 76
About APROCITENTAN
APROCITENTAN is a product associated with $77,374 in payments to 8 healthcare providers, recorded across 76 transactions in the CMS Open Payments database. The primary manufacturer is IDORSIA PHARMACEUTICALS US INC.
Payment data is available from 2023 to 2023. In 2023, $77,374 was paid across 76 transactions to 8 doctors.
The most common payment nature for APROCITENTAN is "Consulting Fee" ($49,881, 64.5% of total).